2019 Hospice Medical director Medicare 
Hospice News
SEPTEMBER 29, 2023
A federal judge has sentenced Jesus Virlar-Cadena, formerly a medical director for the Texas-based hospice company Merida Group, to 50 months in prison for his role in a $152 million scheme. The Texas Medical Board suspended his medical license in 2019, when he pleaded guilty to the fraud charges.
Hospice News
JANUARY 30, 2024
When deprescribing medications for hospice patients, providers have to navigate a complex web of factors. Medication costs are among hospices’ biggest expenses, and deprescribing some medications deemed “curative” or “unrelated” to the patient’s terminal diagnosis is a standard practice. “We
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Hospice News
DECEMBER 22, 2022
These cover the innovative partnerships, new technologies, pediatric care, health equity and other key developments in the hospice space. Pandemic Pushes Death Doula Awareness, Hospices Seek Strengthened Ties. In 2019, the organization had just 200 members.
Hospice News
DECEMBER 21, 2022
Hospice leaders have kept their eyes on four key numbers as 2022 progressed: clinical capacity, length of stay, labor costs and utilization. A fifth, the rising number of new hospices in certain states, has emerged as a priority in recent weeks. These metrics are key to understanding what hospices experienced this year.
Hospice News
MARCH 24, 2023
Hospices and tech companies are increasingly collaborating to help ensure patients receive the right care at the right time and to build efficiencies into care delivery. A rising number of providers are applying these systems to identify hospice-eligible patients more quickly, as well as those in need of palliative care.
Hospice News
MAY 22, 2023
Though older Asian-American adults may be less likely to discuss pain and symptom management needs with their health care professionals, they may be more receptive to the psychosocial support included in hospice and palliative care, according to recent research from VITAS’ Healthcare. between 2010 and 2019. and 20%, respectively.
Pallimed
SEPTEMBER 12, 2022
This unexpectedly and undesirably increased health insurers’ medication costs, including Medicare and Medicaid (22). In response, the American Medical Association (AMA) called against widespread misapplication of the 2016 Guideline, including its embrace of hard dosing thresholds (1, 43).
Expert insights. Personalized for you.
230 
Let's personalize your content